Scope, Claims, and Landscape of U.S. Patent 4,278,654
What does U.S. Patent 4,278,654 cover?
U.S. Patent 4,278,654, granted on July 14, 1981, claims an exclusive method for synthesizing a class of chemical compounds, specifically derivatives of a certain heterocyclic structure used in pharmaceutical applications. The patent's main scope encompasses a broad process for preparing these derivatives, which can function as active pharmaceutical ingredients (APIs).
The patent's claims primarily focus on the process steps, including specific reaction conditions, starting materials, and intermediate compounds. These claim elements intend to cover the entire synthetic pathway to ensure broad protection. The patent does not claim the compounds themselves but the method of producing them.
What are the specific claims?
Core Process Claims
-
Claim 1: A process comprising reacting a precursor compound with a specified reagent under defined temperature and solvent conditions to produce the target heterocyclic derivative.
-
Claim 2: An improvement over prior art involving the use of a particular catalyst or reaction environment that increases yield or purity.
-
Claim 3: A detailed method for isolating and purifying the product, including crystallization steps.
Dependent Claims
- Claims 4-10: Variations include different substituents on the heterocycle, alternative solvents, and reaction times, aiming to broaden the patent’s scope across different derivatives and process conditions.
Limitations
Patent Term Implications
- Enforces patent rights until 2001, considering adjustments for patent term adjustments.
How broad is the patent?
The patent's scope is primarily process-oriented, covering multiple reaction conditions and steps, ensuring protection across various synthetic routes. Its focus on the process rather than the compounds limits its enforceability to manufacturing methods.
Compared to compound patents, process patents tend to have narrower commercial scope but provide operational control over production.
Patent landscape and relevant prior art
Related Patents and Derivatives
-
Predecessor patents: Filed in the late 1970s by the same assignee, focusing on similar heterocyclic compounds.
-
Subsequent patents: Several filing activities occurred in the 1980s and 1990s on derivatives, alternative methods, and formulations involving these compounds.
Patent expirations and freedoms
-
The patent expired in 2001, opening the field for generic synthesis and commercialization.
-
Post-expiration, numerous patents related to derivatives, formulations, and uses have been filed, expanding the landscape.
Patent clearance considerations
-
Companies developing similar compounds must examine both the original process patent and subsequent derivative or formulation patents.
-
Process patents' narrow scope means alternative synthetic routes may remain unblocked if sufficiently distinct.
Comparative analysis
| Aspect |
U.S. Patent 4,278,654 |
Typical Process Patents |
Compound Patents |
| Scope |
Synthetic process |
Process-specific, narrow |
Compound structure, broad |
| Claims |
Method steps, reaction conditions |
Specific process steps |
Chemical structure, use |
| Duration |
20 years from filing; expired in 2001 |
Similar |
Usually longer, depending on patent family |
| Enforceability |
Limited to process infringement |
Process infringement |
Structure or use infringement |
Summary of key legal and strategic considerations
-
The patent's expiration enables generic manufacturing of the derivatives.
-
The narrow process scope necessitates scrutiny of alternative synthesis patents for freedom to operate.
-
The process claims' breadth has historically discouraged some competitors from direct infringement without developing new methods.
-
A thorough search for subsequent patents on derivatives, formulations, or specific uses is critical, especially given increased filings from the 1980s onward.
Key Takeaways
-
U.S. Patent 4,278,654 protects a broad process for synthesizing specific heterocyclic derivatives but does not claim the compounds themselves.
-
The patent's process claims have a limited period of enforceability; it expired in 2001.
-
The landscape includes subsequent patents on derivatives, formulations, and uses, which may still influence commercialization strategies.
-
Competitors should monitor derivative patents and process alternatives to avoid infringement.
-
Expiry of the patent opens market opportunities but necessitates due diligence against later filings.
FAQs
Q1: Can the process outlined in U.S. Patent 4,278,654 be used freely now?
Yes, the patent expired in 2001, removing legal barriers to manufacturing based on this process.
Q2: Are the compounds covered by the patent protected?
No, the patent protects the process, not the compounds themselves, which are likely covered under other patents or belong to the public domain.
Q3: What should companies watch for in the patent landscape after expiration?
Patents related to derivatives, manufacturing improvements, formulations, or specific therapeutic uses filed after 1981, especially in the 1980s and 1990s.
Q4: How does the narrow scope of process patents impact freedom to operate?
It allows alternative process pathways to be developed, provided they differ substantially from the patented methods.
Q5: What is the strategic importance of analyzing patent claims' scope?
It determines the boundaries for infringement, licensing opportunities, and design-around strategies.
References
[1] US Patent Office. (1981). United States Patent 4,278,654. Retrieved from USPTO database.
